Medical/Pharmaceuticals

The 23rd World Congress on Breast Cancer and Breast Healthcare to Be Held in Tianjin

TIANJIN, China, May 8, 2026 /PRNewswire/ -- To further promote academic exchange and practical collaboration in the global field of breast health, and to advance the standardized prevention and treatment of breast cancer, the 23rd World Congress on Breast Cancer and Breast Healthcare will be held...

2026-05-08 17:06 3405

Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, May 8, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today annou...

2026-05-08 17:02 4579

Rznomics Announces U.S. FDA Regenerative Medicine Advanced Therapy Designation Granted to 'RZ-001' for Hepatocellular Carcinoma

RMAT designation based on promising Phase 1b/2a clinical data, including safety profile and preliminary response rates, with trans-splicing ribozyme-based RNA editing platform SEOUL, South Korea, May 8, 2026 /PRNewswire/ -- Rznomics a biopharmaceutical company specializing in RNA-based gene ther...

2026-05-08 16:17 4541

Chance Pharma Announces NMPA Acceptance of New Drug Application for Investigational Respiratory Drug CXG87

HANGZHOU, China, May 7, 2026 /PRNewswire/ -- Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today announced that the Center for Drug Evaluation of China's National Medical P...

2026-05-08 08:30 4402

VARON Highlights Wellness-Focused Mother's Day Gifts That Support Comfort and Independence

NEW YORK, May 7, 2026 /PRNewswire/ -- As families increasingly prioritize meaningful and practical gifts for aging parents and loved ones, VARON is encouraging shoppers to focus on comfort, wellne...

2026-05-08 00:10 4730

For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus

JAKARTA, Indonesia, May 7, 2026 /PRNewswire/ -- In conjunction with World Immunization Week, Pfizer Indonesia, together with healthcare professionals has launched "For the Reasons that Matter", a public awareness campaign focused on adult respiratory health. Rolling out simultaneously across Indo...

2026-05-07 23:05 3837

Fertility patients vulnerable to social media overload of misleading data where evidence and algorithms collide

BEIJING, May 7, 2026 /PRNewswire/ -- Patient information overload dominated by misleading social media and marketing is causing patients experiencing infertility to have unrealistic expectations about treatment success often resulting in psychological distress. "Never before have patients had ...

2026-05-07 14:53 4022

Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Advance Global Scientific Strategy and Innovation

CAMBRIDGE, Mass., May 6, 2026 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the appointment of Dr. Josh Xiao as Chief Scientific Officer (CSO). Dr. Xiao will be...

2026-05-07 11:29 4906

Move towards global consensus guidelines on surrogacy with mounting concerns over human rights violations

BEIJING, May 7, 2026 /PRNewswire/ -- World leaders in assisted reproductive technology are finalising global consensus guidelines on minimal standards in surrogacy to address mounting concerns about severe human rights violations. The standards will attempt to tackle inconsistent or inadequate ...

2026-05-07 09:00 3395

AID 2026 to Showcase Booming Opportunities in Silver Economy

SHANGHAI, May 7, 2026 /PRNewswire/ -- International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare, Shanghai 2026 (hereinafter referred to as AID 2026), widely recognized as China's leading event for the senior care and silver economy sectors, will be held on June 4–6 at Shangh...

2026-05-07 09:00 3359

19.3% Weight Reduction, 16.5 cm Waist Circumference Decrease, SBP/DBP Reductions of 22.9/12.9 mmHg, 70.7 μmol/L Uric Acid Reduction, and 33.6% Triglyceride Reduction: BGM0504 Demonstrates Comprehensive Cardiometabolic Regulation Capabilities

SUZHOU, China, May 6, 2026 /PRNewswire/ -- Recently, BrightGene Bio-Medical Technology Co., Ltd. (hereinafter referred to as "BrightGene Bio-Medical " or "the Company") announced that its proprietary GLP-1 (glucagon-like peptide-1)/GIP (glucose-dependent insulinotropic polypeptide) dual receptor ...

2026-05-07 00:10 4757

ABEC Expands Process Sciences Group to Strengthen Bioprocess Optimization Capabilities

BETHLEHEM, Pa., May 6, 2026 /PRNewswire/ -- ABEC, a global leader in bioprocess engineering solutions, announced the expansion of itsProcess Sciences group, expanding its ability to help biopharmaceutical manufacturers accelerate development, reduce risk, and improve productivity across the biopr...

2026-05-06 22:09 3518

Ribo and Boehringer Ingelheim further progress their siRNA program for metabolic dysfunction-associated steatohepatitis (MASH)

SUZHOU, China and MÖLNDAL, Sweden, May 6, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB ("Ribo", HKEX: 6938) today announced the achievement of a further milestone. This marks the third key milestone achieved in the research collaboration with Boehringer ...

2026-05-06 19:32 5205

(E,E)-bisantrene Discovered to Function via Silencing of c-MYC Expression

Preclinical studies have highlighted how (E,E)-bisantrene silences c-MYC gene expression via G4-DNA binding and stabilization leading to clinically relevant and broad anticancer activity SYDNEY, May 6, 2026 /PRNewswire/ -- Racura Oncology, an Australian Phase 3 stage clinical biopharmaceutical c...

2026-05-06 19:00 4373

China Medical Exhibition 2026: Industries, Products, and Innovations to Watch

SHANGHAI, May 6, 2026 /PRNewswire/ -- The medical device industry moves fast. To stay competitive, you must source the best materials and adopt the latest manufacturing technology before your rivals do. Medtec China serves as the ultimate proving ground for these br...

2026-05-06 17:53 3320

The GBA Healthcare Group and Adventist Health Hong Kong Forge Strategic Partnership for Seamless Specialty Care

Pooling Guangdong–Hong Kong clinical strengths to deliver an end-to-end cross-border care ecosystem spanning direct billing, fast-track referrals and precision specialty matching HONG KONG, May 6, 2026 /PRNewswire/ -- The GBA Healthcare Group ("GBAH") and Adventist Health Hong Kong ("AHHK") toda...

2026-05-06 15:00 3767

Alebund Pharmaceuticals Announces Completion of Patient Enrollment in Global Phase III Pivotal Multi-Regional Clinical Trial of AP301 for Hyperphosphatemia

SHANGHAI, May 6, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced the completion of p...

2026-05-06 12:00 4283

Nona Biosciences Evolves Brand to Reflect Next Phase of Growth in Biotherapeutic Innovation

CAMBRIDGE, Mass., May 5, 2026 /PRNewswire/ -- Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms,announced the launch of its updated global brand identity, marking an important step in the company's continued expansion and e...

2026-05-06 09:30 2945

MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026

GUANGZHOU, China, May 6, 2026 /PRNewswire/ -- MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced positive results from its Phase II clinical trial of QA102 in patients with intermediate dry ...

2026-05-06 08:28 3923

Ascletis to Present Data on Multiple Programs at the 33rd European Congress on Obesity (ECO 2026)

HONG KONG, May 6, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today poster presentations highlighting multiple programs at the 33rd European Congress on Obesity (ECO 2026), taking place May 12-15, 2026 in Istanbul, Türkiye. The presentations include a poster on...

2026-05-06 08:10 5148
1 ... 28293031323334 ... 647

Week's Top Stories